Perioperative interdisciplinary approach for reduction of opioid use in pediatric tonsillectomy: Protocol using

Austin N DeHart1, Jessica Potter2, Justin Anderson3

  • 1Department of Otolaryngology-Head and Neck Surgery, Virginia Commonwealth University Health System, Richmond, VA, United States of America.

Insights

This study shows that using dexmedetomidine and local anesthetic in pediatric tonsillectomy significantly reduces intraoperative opioid use by nearly 50% and improves pain control without increasing adverse events. This safe and effective protocol enhances recovery for young patients.

Area of Science:

  • Anesthesiology
  • Pediatric Surgery
  • Pain Management

Background:

  • Pediatric tonsillectomy is frequently performed for obstructive sleep apnea, a condition linked to heightened sensitivity to opioid side effects.
  • Opioid medications pose risks, including respiratory depression, in pediatric patients.

Purpose of the Study:

  • To evaluate an interdisciplinary protocol using dexmedetomidine and local anesthetic to decrease opioid use in pediatric tonsillectomy.
  • To assess the safety, efficacy, and cost-effectiveness of this anesthetic strategy.

Main Methods:

  • A retrospective case-control study was conducted at a tertiary care hospital.
  • Pediatric patients undergoing tonsillectomy received preoperative dexmedetomidine and local bupivacaine injection.
  • Intraoperative anesthetic and opioid use, postoperative pain scores, and adverse events were analyzed.

Main Results:

  • The protocol reduced intraoperative opioid requirements by 49.6% and sevoflurane use by 18%.
  • Lower maximum postoperative pain scores were reported with no increase in adverse events.
  • The protocol incurred a minimal additional medication cost of $4.07 per procedure.

Conclusions:

  • Dexmedetomidine combined with local anesthetic is a safe and effective approach for pediatric tonsillectomy.
  • This strategy successfully reduces intraoperative opioid administration and improves postoperative pain management.
  • The protocol offers a valuable alternative for minimizing opioid exposure in vulnerable pediatric surgical patients.
Abstract

Related Concept Videos

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
666
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.0K
Oxidation-Reduction Reactions03:11

Oxidation-Reduction Reactions

Oxidation–Reduction Reactions
75.5K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
4.2K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
314
Interdisciplinary Care: The Health Care Team-I01:21

Interdisciplinary Care: The Health Care Team-I

An interdisciplinary team includes many healthcare professionals working together and utilizing their skills, knowledge, and expertise to provide holistic and quality patient care.
Physicians
The physician's primary responsibility is to diagnose illness and direct the medical or surgical treatment of the condition. The authority to admit patients to a healthcare agency or institution and practice care within that setting is granted to physicians by the healthcare agency or institution...
2.6K